INDOCOREMEDIES / bear-case history

Track the concerns that keep returning.

Indoco Remedies · risk themes across the available quarters.

Research layer active

Bear-case history

Risks carried through the record.

High debt and stretched receivables

Consolidated debt stands at ~₹960 crore, with receivables growing 45% YoY due to longer credit periods in emerging markets, straining cash flow.

high

Unresolved sterile plant issue

The sterile plant at Pataganda remains unresolved, limiting future US approvals and requiring ongoing investment without immediate returns.

high

Exchange rate volatility on ECB loan

A €10 million ECB loan caused a ₹24 crore exchange loss in Q4, impacting finance costs; further currency fluctuations could hurt profitability.

medium

Domestic business seasonality risk

Domestic formulation revenue declined 6% YoY due to weak seasonal demand for anti-infectives and respiratory products, with recovery uncertain.

medium